Arch Therapeutics Inc (ARTH)

[F1ash]

One should never invest more than they can afford to lose, especially in these more risky biotechs.

Many companies has a bit of a checkered beginning as they struggle to get their feet under them. You should look at AVXL's beginnings. That company is a 1/4 billion dollar market cap and is just as suspect if not more imho.

Up 2 cents currently so your record of ARTH's death is greatly exaggerated.